BD Revenue and Competitors

Franklin Lakes, NJ USA

Location

$39M

Total Funding

Estimated Revenue & Valuation

  • BD's estimated annual revenue is currently $20.3B per year.(i)
  • BD's estimated revenue per employee is $371,056
  • BD's total funding is $39M.
  • BD's current valuation is $74.9B. (January 2022)

Employee Data

  • BD has 54574 Employees.(i)
  • BD grew their employee count by 4% last year.

BD's People

NameTitleEmail/Phone
1
Staff Product OwnerReveal Email/Phone
2
Associate Product Owner - Microbiology Software EngineeringReveal Email/Phone
3
Supply Chain Planning Owner & BuyerReveal Email/Phone
4
Strategic Customer VP National AccouReveal Email/Phone
5
Area VP SalesReveal Email/Phone
6
Global VP, SustainabilityReveal Email/Phone
7
Group VPReveal Email/Phone
8
Non-Acute, National Sales VPReveal Email/Phone
9
WW VP, Medical AffairsReveal Email/Phone
10
Area VPReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.8M3111%N/AN/A
#2
$12.3M49-4%N/AN/A
#3
$15.1M607%N/AN/A
#4
$8.8M35-8%N/AN/A
#5
$3M129%N/AN/A
#6
$300.4M11973%N/AN/A
#7
$311.7M12422%N/AN/A
#8
$0.3M1-96%N/AN/A
#9
$8.3M333%N/AN/A
#10
$13.6M548%N/AN/A
Add Company

What Is BD?

BD is a medical technology company that serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. BD manufactures and sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products. For the fiscal year ended September 30, 2002, BD reported total revenues of $4.033 billion.

keywords:Biotechnology

$39M

Total Funding

54574

Number of Employees

$20.3B

Revenue (est)

4%

Employee Growth %

$74.9B

Valuation

N/A

Accelerator

BD News

2022-04-20 - BD Looks to Reduce Environmental Impact of Products

s new Sustainable Medical Technology Institute is set to be a model of practice within the organization that will bring together BD...

2022-04-20 - BD Looks to Reduce Environmental Impact of Products

s new Sustainable Medical Technology Institute is set to be a model of practice within the organization that will bring together BD...

2021-11-04 - BD Announces Fourth Fiscal Quarter And Full Year 2021 Results; Issues Fiscal Year 2022 Guidance

FRANKLIN LAKES, N.J., Nov. 4, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for the fourth fiscal quarter and full fiscal year ended September 30, 2021. "Our strong performance in fiscal 2021 was driven ...

2021-10-18 - Becton Dickinson and : BD Launches New 'Together We Advance' Environmental, Social, Governance Strategy; Announces 2030+ Goals to Enhance Stewardship of Human Health, Communities and the Planet

FRANKLIN LAKES, N.J., Oct. 18, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a new strategy to advance environmental, social and governance (ESG) initiatives, as well as a suite of goals for 2030 and beyond that ...

2021-10-13 - Becton Dickinson and : BD Launches Plunger Stopper in Partnership with Aptar Pharma to Enhance Biologic Drug Delivery

New product is intended to support biologic drugs with high viscosity formulations*, complex design space requirements and support the delivery of medications for chronic diseases FRANKLIN LAKES, N.J. (October 13, 2021) - BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical ...